OakChart

Labcorp Holdings Inc

LHHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 11 • 10:00 AM ET

371.25+0.37 (0.10%)
2026-11-11 16:01 CET
Market cap
30,115.46 USD m
Revenue, TTM
14,594.50 USD m
Net income, TTM
1,004.00 USD m
Free cash flow, TTM
1,286.90 USD m
EPS diluted, TTM
12.19
P/E
30.45
Compare

Price

LH against its 20, 50 and 200-day averages
2050200miss
250.00300.00350.00956K1.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LHclose 371.2520-day 346.9850-day 328.02200-day 291.38371.25

0.7% under 373.76 on 9 Nov 2026. Last 15 sessions, 18.7% high to low

Profile

LH
52-week range, 98% of the way up
245373.76

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates through the Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS) segments. The Dx segment includes routine and specialty esoteric testing. The BLS segment consists of central laboratory and ED businesses. The company was founded in 1995 and is headquartered in Burlington, NC.

IndexS&P 500, RUI
Employees71000
IPOJul 07, 1988
Beta0.86
ATR, 14d10.16
Rel volume0.24
Short float3.15%
Insider own0.40%
Inst own100.78%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap30.15B
Enterprise Value36.68B
Income1.00B
Sales14.59B
Book/sh108.96
Cash/sh3.22
Dividend Est.2.95 (0.80%)
Dividend TTM2.88 (0.78%)
Dividend Ex-DateNov 24, 2026
Dividend Gr. 3/5Y10.06% -
Payout27.54%
Employees71000
IPOJul 07, 1988

Ratios

P/E30.45
Forward P/E18.81
PEG1.96
P/S2.07
P/B3.41
P/C115.15
P/FCF23.42
EV/EBITDA15.59
EV/Sales2.51
Quick Ratio1.22
Current Ratio1.41
Debt/Eq0.77
LT Debt/Eq0.68
Option/ShortYes / Yes

Earnings

EPS (ttm)12.19
EPS next Y19.74
EPS next Q4.50
EPS this Y12.58%
EPS next Y6.65%
EPS next 5Y9.61%
EPS past 3/5Y-9.18% -8.01%
Sales past 3/5Y5.55% -0.04%
EPS Y/Y TTM19.63%
Sales Y/Y TTM6.02%
EPS Q/Q3.24%
Sales Q/Q6.92%
EarningsOct 28 BMO
EPS/Sales Surpr.2.93% 1.37%

Ownership

Insider Own0.40%
Insider Trans-5.36%
Inst Own100.78%
Inst Trans-0.75%
ROA5.40%
ROE11.45%
ROIC6.77%
Gross Margin26.87%
Oper. Margin11.26%
Profit Margin6.88%
SMA206.99%
SMA5013.18%
SMA20027.41%
Trades-

Technical

Shs Outstand81.20M
Shs Float80.87M
Short Float3.15%
Short Ratio3.49
Short Interest2.54M
52W High373.76 -0.67%
52W Low245.00 51.53%
Volatility3.24% 3.01%
ATR (14)10.16
RSI (14)71.24
Beta0.86
Rel Volume0.24
Avg Volume730.02K
Volume21,766

Performance

Perf Week0.94%
Perf Month18.37%
Perf Quarter15.08%
Perf Half Y45.92%
Perf YTD47.98%
Perf Year38.42%
Perf 3Y81.29%
Perf 5Y50.64%
Perf 10Y246.22%
Recom1.60
Target Price392.93
Prev Close370.88
Price371.25
Change %0.10%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 05, 2026UpgradeHHSBC SecuritiesHold → Buy$410+10.4%
Jul 10, 2025DowngradeHHSBC SecuritiesBuy → Hold$260-30.0%
Apr 02, 2025InitiatedRRedburn AtlanticBuy$276-25.7%
Mar 04, 2025UpgradeCCitigroupNeutral → Buy$250 → $300-19.2%
Jan 07, 2025UpgradeEEvercore ISIIn-line → Outperform$260 → $265-28.6%
Dec 10, 2024ResumedJJefferiesBuy$265 → $275-25.9%
Oct 30, 2024UpgradeHHSBC SecuritiesHold → Buy
Oct 01, 2024InitiatedPPiper SandlerNeutral$235-36.7%
Mar 25, 2024UpgradeAArgusHold → Buy$250-32.7%
Feb 26, 2024InitiatedLLeerink PartnersOutperform$260-30.0%

Peers

Mkt cap
TickerCompanyMkt cap
DGXQuest Diagnostics Inc28.50B
ICLRIcon Plc15.24B
CRLCharles River Laboratories International Inc16.66B
IQVIQVIA Holdings Inc45.74B
MEDPMedpace Holdings Inc18.69B
NTRANatera Inc45.71B
TMOThermo Fisher Scientific Inc267.32B
GHGuardant Health Inc21.62B
NEONeogenomics Inc2.21B
FTREFortrea Holdings Inc2.02B

Insider trading

latest 14 of 42
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Caveney Brian JOfficerNov 10 '26Proposed Sale372.042,000744,080Nov 10 04:04 PM
Vaughn Bryan TEVP and President, DiagnosticsNov 03 '26Sale353.70306108,2326,845Nov 05 08:00 AM
Bailey Megan D.Former OfficerNov 04 '26Proposed Sale361.163,0351,096,121Nov 04 11:33 AM
Vaughn Bryan TOfficerNov 03 '26Proposed Sale353.70306108,232Nov 03 10:42 AM
Parham Richelle PDirectorOct 30 '26Sale361.221,078389,3952,288Nov 03 10:17 AM
Parham Richelle PDirectorOct 30 '26Proposed Sale361.221,078389,395Oct 30 11:48 AM
ANDERSON KERRII BDirectorAug 17 '26Sale318.023,000954,0606,563Aug 18 08:10 AM
KERRII B ANDERSONDirectorAug 17 '26Proposed Sale318.133,000954,390Aug 17 04:31 PM
Schechter Adam HPresident & CEOAug 11 '26Sale320.374,6691,495,808102,565Aug 12 02:31 PM
Schechter Adam HOfficerAug 11 '26Proposed Sale320.374,6691,495,808Aug 11 10:06 AM
Summy Amy B.EVP, Chief Marketing OfficerAug 04 '26Sale306.74924283,4286,956Aug 06 08:26 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 03 '26Option Exercise209.251,338279,9763,108Aug 05 11:17 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 03 '26Sale309.231,420439,1071,770Aug 05 11:17 AM
Summy Amy B.OfficerAug 04 '26Proposed Sale306.74924283,428Aug 04 11:58 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VOEVanguard Morningstar Mid-Cap Value ETFAUM: 24.66B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B

News

latest 14 of 206
  • Labcorp completes $375M Millennium Health takeover (MedTech Dive)
  • Labcorp to Speak at the UBS Global Healthcare Conference (PR Newswire)
  • The big winners of the tech wreck are biopharma stocks (MarketWatch)
  • Labcorp Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.78%
  • Labcorp: Q3 Earnings Snapshot (Associated Press)
  • Loading…
  • LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs Heres Whats Driving Investor Enthusiasm (Stocktwits)
  • Labcorp's Organic Acceleration Drives A Third Guidance Raise, But A $125 Million PAMA Hit Clouds 2027 (Earnings Whispers)
  • Labcorp Shares Rise 1.5% as Q3 Earnings Beat Forecasts and Full-Year Guidance Increases (InvestorsHub)
  • Labcorp Boosts FY26 Outlook - Update (RTT News)
  • Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance (PR Newswire)
  • Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 (PR Newswire)
  • Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential (PR Newswire)
  • Labcorp Declares Quarterly Dividend (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-284.7804.6443.2203,8103,75914
2026Q22026-07-304.9904.7793.6433,7313,70915
2026Q12026-04-304.2504.1103.3513,5383,50916
2025Q42026-02-174.0703.9461.9803,5163,55916
2025Q32025-10-284.1804.1303.1203,5643,55816
2025Q22025-07-244.3504.1682.8363,5273,48616
2025Q12025-04-293.8403.7422.5243,3453,39916
2024Q42025-02-063.4503.3921.7033,3293,30815
2024Q32024-10-243.5003.4732.0063,2823,26116
2024Q22024-08-013.9403.7762.4353,2213,18515
2024Q12024-04-253.6803.4842.6923,1773,11816
2023Q42024-02-153.3003.257-1.9683,0333,01814
2023Q32023-10-263.3803.3332.1073,0572,99213
2023Q22023-07-273.4203.8362.1233,0343,76713
2023Q12023-04-253.2823.3992.3923,7783,69213
2022Q42023-02-163.5573.5250.8553,6743,74113

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY9.7259.6708.35511,55511,530
2020FY20.56618.40615.87913,97913,540
2021FY24.50123.84024.38316,12116,009
2022FY17.13017.07413.96414,87714,942
2023FY13.56013.5374.77212,16212,146
2024FY14.57014.5228.83913,00912,987
2025FY16.44016.33210.46013,95213,992
2026FY-18.508--14,828
2027FY-19.738--15,644
2028FY-21.650--16,429
2029FY-24.025--17,657
2030FY-26.160---

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0212603,7533,6953,787
2026Q4S2026-10-2812603,7503,6953,787
2026Q4S2026-10-0111003,7193,6813,737
2026Q4S2026-09-2111003,7163,6533,737
2026Q4S2026-09-1011003,7173,6533,737
2026Q4S2026-09-0911003,7163,6533,737
2026Q4S2026-08-0611003,7163,6533,737
2026Q4S2026-07-3111003,7133,6533,737
2026Q4S2026-07-3011003,7143,6533,737
2026Q4S2026-07-1011003,7083,6533,741
2026Q4S2026-07-0211003,7093,6533,741
2026Q4S2026-06-2111003,7093,6593,741
2026Q4S2026-05-3111013,7093,6593,741
2026Q4S2026-05-2812013,7013,6143,741

Estimate history

EPS, annual11.818.6138.35515.87924.38313.9644.7728.83910.45912.1939
Period201720182019202020212022202320242025TTM
EPS, quarterly2.0061.7032.5242.8363.121.983.3513.6433.221
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1030811333.411554.813978.516120.911863.912161.613008.913951.714594.5
Period201720182019202020212022202320242025TTM
Sales, quarterly32823329.43345.13527.33563.53515.83537.63731.13810
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual101.998.997.297.593.188.283.983.482.281.2
Period201720182019202020212022202320242025MRQ
Shares, quarterly83.783.483.882.98382.282.380.981.2
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue14,594.5013,951.7013,008.9012,161.6011,863.9016,120.9013,978.5011,554.8011,333.40
Cost of Goods Sold Incl. D&A10,672.4010,219.209,640.909,016.508,348.6010,866.209,301.108,545.508,388.70
Gross Profit3,922.103,732.503,368.003,145.103,515.305,254.704,677.403,009.302,944.70
Selling, General and Administrative Excl. Other2,278.202,216.302,230.002,021.401,763.101,894.101,707.801,569.401,570.90
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,643.901,516.201,138.001,123.701,752.203,360.602,969.601,439.901,373.80
Interest Expense230.30224.10208.30199.60179.80212.10207.40240.70244.20
Unusual Expense141.80142.6051.30398.10315.70101.10524.20114.9048.10
Net Income Before Taxes1,224.701,107.50959.50568.901,237.403,126.602,219.101,104.901,268.30
Income Taxes219.60229.80212.40188.50233.90747.10662.10280.00384.40
Consolidated Net Income1,005.10877.70747.10380.401,003.502,379.501,557.00824.90883.90
Net Income From Continuing Operations1,004.00876.50746.00379.201,002.002,377.301,556.10823.80883.70
Net Income1,004.00876.50746.00418.001,279.102,377.301,556.10823.80883.70
EPS (Recurring)13.5211.659.267.9516.3825.1119.629.178.94
EPS (Basic, Before Extraordinaries)12.2710.538.894.8014.0424.5815.998.418.71
EPS (Diluted)12.1910.468.844.7713.9624.3815.888.368.61
EBITDA2,352.202,477.302,037.901,704.602,289.404,300.603,794.602,211.201,925.90
Non-Operating Income (Expense)-47.10-42.0081.1042.90-19.3079.20-18.9020.60186.80
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense100.4199.3892.19116.37113.84112.2081.5478.1172.36
Price To Earnings Ratio30.4230.4244.4030.4010.8011.0811.0517.3912.61
Price To Sales Ratio1.721.511.491.641.821.901.431.441.14
Gross Margin26.8726.7525.8925.8629.6332.6033.4626.0425.98
Operating Margin11.2610.878.759.2414.7720.8521.2412.4612.12
Net Margin6.886.285.733.4410.7814.7511.137.137.80
Shares Outstanding81.2082.2083.4083.9088.2093.1097.5097.2098.90
Market Capitalization30,115.4630,115.4619,180.1619,296.9217,923.2925,832.2317,031.7814,111.4810,952.94

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,810.003,731.103,537.603,515.803,563.503,527.303,345.103,329.40
Cost of Goods Sold Incl. D&A2,780.602,697.202,599.402,595.202,607.902,549.402,466.702,503.50
Gross Profit1,029.401,033.90938.20920.60955.60977.90878.40825.90
Selling, General and Administrative Excl. Other611.40577.20551.00538.60552.40579.30546.00595.20
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income418.00456.70387.20382.00403.20398.60332.40230.70
Interest Expense59.1061.1055.1055.0056.0057.1056.0063.40
Unusual Expense15.905.106.40114.406.604.106.4014.20
Net Income Before Taxes328.00386.40319.70190.60337.00304.70275.20183.80
Income Taxes64.9087.3041.7025.7075.5066.4062.2040.20
Consolidated Net Income263.10299.10278.00164.90261.50238.30213.00143.60
Net Income From Continuing Operations262.80298.70277.80164.70261.10237.90212.80143.40
Net Income262.80298.70277.80164.70261.10237.90212.80143.40
EPS (Recurring)3.363.693.412.943.172.872.581.82
EPS (Basic, Before Extraordinaries)3.243.663.382.003.142.852.551.72
EPS (Diluted)3.223.643.351.983.122.842.521.70
EBITDA601.00635.70560.50555.00574.20568.90499.20401.30
Non-Operating Income (Expense)-15.00-4.10-6.00-22.00-3.60-32.705.2030.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense24.3327.5725.0423.4623.0726.9425.9121.57
Price To Earnings Ratio30.4224.8125.5124.6431.6530.2826.3444.40
Price To Sales Ratio1.721.601.561.501.751.631.491.48
Gross Margin27.0227.7126.5226.1826.8227.7226.2624.81
Operating Margin10.9712.2410.9510.8711.3111.309.946.93
Net Margin6.908.017.854.687.336.746.364.31
Shares Outstanding81.2080.9082.3082.2083.0082.9083.8083.40
Market Capitalization30,115.4622,960.0021,985.1420,797.9523,854.6921,963.8419,480.3419,180.16

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments532.301,518.70536.80320.601,472.701,320.80337.50426.80316.60
Short Term Receivables2,260.702,097.002,098.701,997.302,978.303,016.602,025.301,862.301,847.50
Inventories534.70493.20474.60470.60401.40423.20244.70237.30227.20
Other Current Assets692.80697.60655.301,836.50478.10364.80373.70309.00342.50
Total Current Assets4,020.504,806.503,765.404,625.005,330.505,125.402,981.202,835.402,733.80
Net Property, Plant & Equipment3,081.503,045.402,911.802,794.102,815.402,729.602,636.601,784.701,706.60
Total Investments and Advances153.9016.3026.9065.7063.80164.1089.6060.5058.40
Long-Term Note Receivable---0.700.705.70---
Intangible Assets10,385.509,858.609,484.509,247.3011,694.4011,712.6011,899.5011,271.4011,567.00
Deferred Tax Assets--0.006.4021.6020.608.801.701.90
Other Assets751.30652.20536.503,416.60459.00313.70430.70231.60605.30
Total Assets18,392.7018,379.0016,725.1020,155.1020,385.4020,071.7018,046.4016,185.3016,673.00
Short Term Debt Incl. Current Port. of LT Debt695.801,191.001,172.00471.10199.00575.40630.1017.90417.50
Accounts Payable840.80875.80827.50852.20621.30638.90632.30634.60573.90
Income Tax Payable160.30152.70127.50105.60239.60374.80156.70124.8070.60
Other Current Liabilities1,126.601,110.701,098.201,649.601,723.001,489.401,236.701,101.601,123.70
Total Current Liabilities2,823.503,330.203,225.203,078.502,782.903,078.502,655.801,878.902,185.70
Long Term Debt5,830.206,081.804,782.205,775.306,143.606,181.006,477.506,041.906,344.60
Provision for Risks Charges0.000.000.000.00262.80323.60272.90186.40232.20
Deferred Tax Liabilities454.50383.10417.90543.40762.90905.40942.80940.00875.50
Other Liabilities647.80517.40409.30642.40139.20202.80110.30147.60210.10
Total Liabilities9,756.0010,312.508,834.6010,039.6010,091.4010,691.3010,459.309,194.809,848.10
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity8,619.808,052.207,875.0010,096.6010,273.409,359.707,567.006,971.406,804.10
Total Shareholders Equity8,619.808,052.207,875.0010,096.6010,273.409,359.707,567.006,971.406,804.10
Accumulated Minority Interest16.9014.3015.5018.9020.6020.7020.1019.1020.80
Total Equity8,636.708,066.507,890.5010,115.5010,294.009,380.407,587.106,990.506,824.90
Total Liabilities & Stockholders Equity18,392.7018,379.0016,725.1020,155.1020,385.4020,071.7018,046.4016,185.3016,673.00
Book Value Per Share104.8696.5593.86114.47110.3596.0077.8570.4966.77
Tangible Book Value Per Share-21.48-21.66-19.189.63-15.26-24.13-44.57-43.48-46.74
Full-Time Employees71,00070,00067,00080,00075,50072,40065,00061,00060,000
Price to Book Ratio3.402.352.451.802.451.821.871.542.28
Return on Assets4.774.252.064.9411.758.164.815.387.94
Return on Equity10.519.374.229.8424.2218.3911.3312.8319.94
Return on Invested Capital6.075.283.308.0614.4810.015.876.799.33
Quick Ratio1.231.301.021.351.771.531.031.381.15
Current Ratio1.421.441.171.501.921.661.121.511.25

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,005.10877.70747.10419.201,280.602,379.501,557.00824.90883.90
Depreciation708.30681.10643.50577.30537.20940.00624.70577.20552.10
Other Funds (Non Cash)501.70510.20369.40771.20488.00129.70857.50307.80-82.50
Funds from Operations2,287.102,166.601,739.901,689.602,332.103,373.302,992.201,739.101,375.70
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-472.10-526.10-154.10-361.90-376.20-263.70-856.90-294.40-70.30
Cash from Operating Activities1,815.001,640.501,585.801,327.701,955.903,109.602,135.301,444.701,305.40
Capital Expenditures-528.10-434.50-489.90-453.60-429.30-460.40-381.70-400.20-379.80
Net Assets From Acquisitions-941.40-582.00-839.00-671.50-1,164.00-496.90-267.60-876.00-117.80
Sale of Fixed Assets and Businesses4.508.0017.100.603.0087.3042.107.7053.80
Purchase or Sale of Investments-47.10-185.50-55.00-22.30-12.20-14.60-39.10-16.30-22.30
Purchase of Investments-47.10-192.40-55.00-29.00-17.40-27.80-40.10-27.50-22.30
Sale Or Maturity of Investments0.006.900.006.705.2013.201.0011.200.00
Other Uses0.000.000.00-24.70-52.600.000.000.000.00
Other Sources0.200.000.000.002.900.003.101.70672.80
Cash from Investing Activities-1,511.90-1,194.00-1,366.80-1,171.50-1,652.20-884.60-643.20-1,283.10206.70
Cash Dividends Paid-237.40-240.70-243.10-254.00-195.200.000.000.000.00
Change in Capital Stock-592.60-395.70-193.90-945.60-1,049.40-1,616.80-44.10-385.30-630.90
Repurchase of Common Pref Stock-676.80-450.00-250.10-1,000.00-1,100.00-1,668.50-100.00-450.00-700.00
Sale of Common Pref Stock84.2054.3056.2054.4050.6051.7055.9064.7069.10
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net250.00-1,000.001,000.00-300.000.00-375.00-412.20198.50-704.60
Change in Long Term Debt250.00-1,000.001,000.00-300.000.00-375.00-412.20198.50-704.30
Issuance of Long Term Debt750.0064.804,463.702,488.20787.401,000.00151.702,383.40467.20
Reduction of Long Term Debt-500.00-1,064.80-3,463.70-2,788.20-787.40-1,375.00-563.90-2,184.90-1,171.50
Net Financing Active Other Cash Flow-59.80179.40216.901,440.30-77.60-74.00-61.10-65.90-54.40
Other Financing Activities Uses-461.10-45.60-83.10-59.40-77.60-74.00-61.10-65.90-6.40
Cash from Financing Activities-639.80-1,457.00779.90-59.30-1,322.20-2,065.80-517.40-252.70-1,389.90
Exchange Rate Effect0.4024.10-17.009.90-24.20-7.308.601.80-12.00
Net Change in Cash-336.30-986.40981.90106.80-1,042.70151.90983.30-89.30110.20
Free Cash Flow1,286.901,206.001,095.90874.101,526.602,649.201,753.601,044.50925.60
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow23.9621.7822.7032.1116.2011.5611.3815.9714.01
Deferred Taxes & Investment Tax Credit-97.60-20.10-78.1026.30-75.90-47.0029.2022.20

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments261.80141.80981.10532.30598.10647.30
Short Term Receivables2,558.702,504.802,450.502,260.702,265.202,276.70
Inventories538.40562.20497.70534.70521.50508.10
Other Current Assets607.30606.10629.50692.80694.00655.10
Total Current Assets3,966.203,814.904,558.804,020.504,078.804,087.20
Net Property, Plant & Equipment3,142.703,100.503,065.503,081.503,112.803,133.80
Total Investments and Advances354.60139.30146.60153.90168.20160.40
Intangible Assets10,894.0010,708.3010,591.3010,385.5010,253.7010,045.50
Other Assets567.10769.30724.90751.30648.10633.00
Total Assets18,924.6018,532.3019,087.1018,392.7018,261.6018,059.90
Short Term Debt Incl. Current Port. of LT Debt788.90185.90688.20695.80691.10690.00
Accounts Payable738.00688.50695.70840.80668.50793.00
Income Tax Payable---160.30--
Other Current Liabilities1,292.701,250.201,257.101,126.601,269.601,233.80
Total Current Liabilities2,819.602,124.602,641.002,823.502,629.202,716.80
Long Term Debt5,987.006,580.206,552.405,830.205,838.805,856.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities528.50486.70456.40454.50441.50354.50
Other Liabilities725.60717.60691.80647.80639.10643.20
Total Liabilities10,060.709,909.1010,341.609,756.009,548.609,570.50
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity8,847.808,606.808,728.608,619.808,696.908,472.70
Total Shareholders Equity8,847.808,606.808,728.608,619.808,696.908,472.70
Accumulated Minority Interest16.1016.4016.9016.9016.1016.70
Total Equity8,863.908,623.208,745.508,636.708,713.008,489.40
Total Liabilities & Stockholders Equity18,924.6018,532.3019,087.1018,392.7018,261.6018,059.90
Book Value Per Share108.96106.39106.06104.86104.78102.20
Tangible Book Value Per Share-25.20-25.98-22.63-21.48-18.76-18.97
Full-Time Employees---71,000--
Price to Book Ratio3.402.642.542.392.812.65
Return on Assets5.405.485.134.774.644.39
Return on Equity11.4511.7411.0510.5110.149.27
Return on Invested Capital1.771.971.821.141.801.66
Quick Ratio1.221.531.541.231.351.32
Current Ratio1.411.801.731.421.551.50

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income263.10299.10278.00164.90261.50238.30
Depreciation183.00179.00173.30173.00171.00170.30
Other Funds (Non Cash)99.8098.2091.10212.6085.20122.90
Funds from Operations570.30600.70544.40571.70606.30525.40
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-6.50-155.20-352.9042.50-219.1095.20
Cash from Operating Activities563.80445.50191.50614.20387.20620.60
Capital Expenditures-151.60-131.60-121.00-123.90-106.70-77.90
Net Assets From Acquisitions-255.50-225.70-202.20-258.00-260.50-10.00
Sale of Fixed Assets and Businesses-9.701.907.804.501.101.90
Purchase or Sale of Investments-17.10-10.80-6.70-12.50-1.00-15.00
Purchase of Investments-17.10-10.80-6.70-12.50-7.90-15.00
Sale Or Maturity of Investments0.000.000.000.006.900.00
Other Uses0.000.000.000.000.000.00
Other Sources0.200.000.000.00-6.906.90
Cash from Investing Activities-433.70-366.20-322.10-389.90-374.00-94.10
Cash Dividends Paid-58.20-58.70-61.20-59.30-59.90-59.90
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock49.50-352.00-65.10-225.003.60-200.00
Repurchase of Common Pref Stock0.00-353.80-98.00-225.00-25.00-200.00
Sale of Common Pref Stock49.501.8032.900.0028.600.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-500.00750.000.000.000.00
Change in Long Term Debt0.00-500.00750.000.000.000.00
Issuance of Long Term Debt0.000.00750.000.000.000.00
Reduction of Long Term Debt0.00-500.000.000.000.000.00
Net Financing Active Other Cash Flow-1.30-9.20-43.20-6.10-3.20-7.50
Other Financing Activities Uses-227.60-184.20-43.20-6.10-3.20-7.50
Cash from Financing Activities-10.00-919.90580.50-290.40-59.50-267.40
Exchange Rate Effect-0.101.30-1.100.30-2.9018.80
Net Change in Cash120.00-839.30448.80-65.80-49.20277.90
Free Cash Flow412.20313.9070.50490.30280.50542.70
Price to Free Cash Flow23.9625.0619.3421.6221.0921.60

Revenue breakdown

Europe2024: 1.17B 2025: 1.26B
North America2024: 11.32B 2025: 12.14B
Other countries2024: 520.36M 2025: 558.07M
Biopharma Laboratory Services2024: 2.86B 2025: 3.07B
Diagnostics2024: 10.15B 2025: 10.88B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.15%2.5M80.9M717.19K
2026-10-153.17%2.6M80.8M734.27K
2026-09-303.32%2.7M80.8M731.33K
2026-09-153.03%2.4M80.8M705.17K
2026-08-312.60%2.1M80.8M672.04K
2026-08-142.40%1.9M80.8M660.50K
2026-07-312.59%2.1M80.8M696.67K
2026-07-153.33%2.7M81.7M658.31K
2026-06-303.47%2.8M81.7M655.06K
2026-06-154.00%3.3M81.6M625.82K
2026-05-294.20%3.4M81.7M620.83K
2026-05-154.13%3.4M81.7M654.75K
2026-04-303.87%3.2M81.7M654.73K
2026-04-153.95%3.2M82.1M656.22K
2026-03-313.89%3.2M82.1M701.56K
2026-03-133.64%3.0M82.1M711.43K
2026-02-273.90%3.2M82.1M722.39K
2026-02-133.68%3.0M82.1M724.11K
2026-01-303.86%3.2M82.6M816.03K
2026-01-153.67%3.0M82.6M841.48K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call155214.22180.003.1270.000.000.988-0.2780.018
call160209.22130.003.0220.000.000.988-0.2780.019
call1652042080.002.9220.000.000.987-0.2770.019
call170199203139.72.8241.000.000.987-0.2760.020
call1751941980.002.7290.000.000.986-0.2760.020
call18018919383.202.6311.000.000.986-0.2750.021
call1851841880.002.5470.000.000.985-0.2740.022
call1901791830.002.4540.000.000.985-0.2740.022
call1951741780.002.3690.000.000.984-0.2730.023
call2001691730.002.2860.000.000.984-0.2720.024
call2101591630.002.1320.000.000.982-0.2700.025
call220149.11530.001.9790.000.000.981-0.2680.027
call2301391430.001.8320.000.000.980-0.2650.029
call24012913385.601.6884.000.000.978-0.2620.031
call25011912323.101.55621.000.000.976-0.2590.033
call26010911371.451.4256.000.000.974-0.2560.035
call27099.0010347.001.2984.000.000.972-0.2520.038
call28089.0093.0081.281.17427.000.000.969-0.2480.041
call29079.0083.0072.421.05419.000.000.965-0.2430.045
call30069.0073.0052.000.93612.000.000.961-0.2370.049
call31059.5063.0059.900.82076.000.000.956-0.2300.054
call32049.5053.0046.870.70610.000.000.950-0.2220.060
call33039.5043.4035.960.63110.000.000.941-0.2120.069
call34029.5033.5027.580.52071.000.000.910-0.2500.095
call35020.5024.3022.000.45071.000.000.795-0.4630.167
call36012.0015.9011.410.3932700.000.697-0.4830.205
call3705.509.408.500.37117.000.000.538-0.5040.233
call3801.354.903.900.36094.000.000.359-0.4560.219
call3900.103.602.200.4361960.000.246-0.4500.185
call4000.002.650.720.53323.000.000.206-0.5090.167
call4100.000.950.500.4406.000.000.083-0.2190.089
put1550.002.150.002.7000.000.00-0.012-0.2690.018
put1600.002.150.002.6100.000.00-0.012-0.2680.019
put1650.002.150.002.5230.000.00-0.013-0.2670.019
put1700.002.150.002.4380.000.00-0.013-0.2650.020
put1750.002.151.732.3554.000.00-0.014-0.2640.020
put1800.002.152.552.27516.000.00-0.014-0.2630.021
put1850.002.152.792.1974.000.00-0.015-0.2620.022
put1900.002.150.002.1210.000.00-0.015-0.2600.022
put1950.002.150.002.0480.000.00-0.016-0.2590.023
put2000.002.150.001.9750.000.00-0.016-0.2570.024
put2100.002.150.001.8360.000.00-0.017-0.2540.025
put2200.002.154.401.7037.000.00-0.019-0.2510.027
put2300.002.150.381.57520.000.00-0.020-0.2470.029
put2400.002.150.771.45219.000.00-0.022-0.2440.031
put2500.002.157.201.3363.000.00-0.024-0.2400.033
put2600.001.701.421.2213.000.00-0.026-0.2350.035
put2700.002.152.011.11023.000.00-0.028-0.2300.038
put2800.001.000.160.9997660.00-0.031-0.2240.041
put2900.002.150.900.8967600.00-0.034-0.2180.045
put3000.001.100.050.7901110.00-0.039-0.2110.049
put3100.002.150.550.6881630.00-0.044-0.2030.054
put3200.002.150.110.5882560.00-0.050-0.1940.061
put3300.000.750.380.49113.000.00-0.059-0.1840.069
put3400.001.000.350.42010.000.00-0.089-0.2190.095
put3500.303.503.850.49932.000.00-0.200-0.4250.164
put3601.305.002.590.42020.000.00-0.303-0.4520.205
put3704.508.4015.900.3981.000.00-0.460-0.4740.233
put38010.7014.0013.010.3852.000.00-0.641-0.4220.219
put39018.2022.000.000.4510.000.00-0.750-0.4190.186
put40027.5031.5028.690.5282.000.00-0.820-0.3850.154
put41037.5041.0038.500.6102.000.00-0.917-0.1820.089

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-218-KCurrent report2026-10-20SEC
2026-09-308-KCurrent report2026-09-30SEC
2026-09-228-KCurrent report2026-09-22SEC
2026-09-108-KCurrent report2026-09-10SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-288-KCurrent report2026-08-28SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-148-KCurrent report2026-08-11SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100108.23K1
2026-1000389.40K1
2026-090000
2026-08003.17M4
2026-070093.30K2
2026-0600201.08K1
2026-05001.50M1
2026-040000
2026-03003.10M3
2026-02002.34M7
2026-010000
2025-120000
2025-11001.51M1

Institutional holders

Manager% owned
BlackRock, Inc.8.02%
VANGUARD CAPITAL MANAGEMENT LLC6.54%
VICTORY CAPITAL MANAGEMENT INC4.83%
STATE STREET CORP4.77%
FMR LLC4.55%
VANGUARD PORTFOLIO MANAGEMENT LLC4.49%
Boston Partners3.64%
GEODE CAPITAL MANAGEMENT, LLC2.70%
Allspring Global Investments Holdings, LLC2.56%
Select Equity Group, L.P.2.42%

Funds

Fund% owned
Global Equity Fund3.27%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
VANGUARD 500 INDEX FUND2.59%
VANGUARD MID-CAP INDEX FUND2.17%
Allspring Special Mid Cap Value Fund1.87%
Victory Sycamore Established Value Fund1.76%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.31%
Victory Pioneer Fund1.28%
Empower Bond Index Fund1.22%

OakChart. LH. Cached 15 minutes.